[-] Show simple item record

dc.contributor.authorTrammell, Saraeng
dc.contributor.authorShakil, Amereng
dc.contributor.authorWilder, Lauraeng
dc.date.issued2005eng
dc.description.abstractWhen the standard therapies -- mild topical corticosteroids and moisturizers -- fail in the treatment of atopic dermatitis, patients are left with few proven remedies. The recently introduced topical immunosuppressive treatment --pimecrolimus and tacrolimus -- offer an alternative to topical corticosteroids. Tacrolimus 0.1% (Protopic) appears to be both safe and effective in treating eczema in adults and children (strength of recommendation [SOR]: A). In multiple studies, it has been as effective as potent topical corticosteroids and more effective than mild topical corticosteroids (SOR: A). Pimecrolimus (Elidel) is more effective than placebo but less effective than potent topical corticosteroids (SOR: A). At this time, no data compare pimecrolimus with mild corticosteroids.eng
dc.identifier.urihttp://hdl.handle.net/10355/3381eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2005 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 54, no. 08 (August 2005)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjecteczemaeng
dc.subjecttopical immunosuppressanteng
dc.subjectcorticosteroidseng
dc.subject.lcshAtopic dermatitiseng
dc.subject.lcshEczemaeng
dc.subject.lcshAdrenocortical hormoneseng
dc.subject.lcshFK-506 (Drug)eng
dc.titleWhat is the role of tacrolimus and pimecrolimus in atopic dermatitis?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record